Polycystic ovary syndrome: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• GLP-1 4
• PPAR 0
• AKT 0
• AMPK 0
• IL-6 0
• PI3K 0
• TNF 1
• VEGF 0
• GIP 0
• mTOR 0
• TLR4 0
• BDNF 0
• DPP-4 0
• HMGB1 0
• IL-1 0
• MAPK 0
• SIRT1 0
• STAT3 0
• AR 0
• CD40 0
• FTO 0
• IGF1R 0
• MMP-9 0
• PCSK9 0
• PD-1 0
• PD-L1 0
• PINK1 0
• PNPLA3 1
• PTEN 0
• SGLT2 0
• STING 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Elucidating the role of maternal nutrient stores in the metabolism of the preimplantation embryo (MaterMeta)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Cell type-specific endometrial dysfunctions across the menstrual cycle and their potential for drug interventions in polycystic ovary syndrome (POTRET)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 236 340 EUR· until 2028. júl.

• European Commission (Horizon 2020) · RIA

  PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY (SPIOMET4HEALTH)

  Fundacio Privada Per A la Recerca I la Docencia Sant Joan de Deu· Esplugues De Llobregat, Spanyolország· EU contribution 6 366 149 EUR· until 2026. dec.· 9 countries

3 of 3 running projects, newest first. Listed amounts together: 6,9 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 9
• Organoids 4
• Mendelian Randomization Analysis 23
• CRISPR-Cas Systems 1
• Gene Expression Profiling 19
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 1
• Proteomics 13
• Metabolomics 22
• Mass Spectrometry 4
• Flow Cytometry 3
• Immunohistochemistry 6
• Magnetic Resonance Imaging 9
• Machine Learning 24
• Deep Learning 6
• Cohort Studies 75
• Genome-Wide Association Study 35

• Multi-omics biomarkers in endometrial receptivity: from mechanisms to clinical translation.

  J Transl Med, 2026. jún.

• Advancing PCOS drug development: multi-omics discovery of key targets and repurposable compounds.

  Naunyn Schmiedebergs Arch Pharmacol, 2026. máj.

• PCOS combined with obesity aggravates the metabolic and immune abnormality in females.

  BMC Womens Health, 2026. ápr.

• Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome.

  Nat Genet, 2026. ápr.

• Follicular fluid proteomic alterations associated with oocyte developmental potential in polycystic ovary syndrome.

  Front Endocrinol (Lausanne), 2026. ápr.

• Integrative metabolomics and proteomics reveal early cardiovascular risk signatures in PCOS female offspring.

  J Ovarian Res, 2026. febr.

• Proteomic Characterization of Necroptosis-Related Proteins Reveals the Role of Endometrial Dysfunction in Predicting Pregnancy Outcomes in Polycystic Ovary Syndrome.

  Front Biosci (Landmark Ed), 2025. nov.

• Increased Serum Levels of LDHA and TPI1 in Patients With Polycystic Ovary Syndrome.

  Proteomics Clin Appl, 2025. nov.

• Effect of metformin on the endometrial proteome of diet-induced obese mice.

  J Mol Endocrinol, 2025. ápr.

• Tandem mass tag-based proteomic analysis of granulosa and theca interna cells of the porcine ovarian follicle following in vitro treatment with vitamin D3 and insulin alone or in combination.

  J Proteomics, 2024. szept.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.